PDCD1 and neoplasm: Treatment with oncolytic virus and immune checkpoint blockade combines the initial local effects of the oncolytic virus on the tumor microenvironment with the systemic effects of innate and adaptive immune responses from virus replication and PD-1 inhibition7.